🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Japan / NCT05347069
Recruiting Phase 4

Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization

NCT05347069 · tracked via the Priya Life Science Japan tracker
Sponsor
Takeshi Morimoto
Phase
Phase 4
Started
2022-06-14
Last updated
2025-03-11

Condition(s) studied

Stable Angina PectorisCoronary Artery DiseaseIschemic Heart Disease

Investigational drug(s) / intervention(s)

Aspirin →No aspirin →

Aspirin: Aspirin 100 mg/day

No aspirin: No aspirin administered

Study summary

The purpose of this study is to evaluate the efficacy and safety aspirin in patients with chronic coronary syndromes without revascularization.

Eligibility

Sex
ALL
Min age
20 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients with chronic coronary syndromes with ≧50% diameter stenosis in one or more major coronary vessels/major branches on coronary CT or coronary angiography but not eligible for coronary revascularization * Patients for whom consent can be obtained Exclusion Criteria: * Patients with history of acute coronary syndromes (ACS) * Patients with history of percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) * Patients with left main trunk stenosis (≥50%) * Patients for whom aspirin administration is mandatory * Patients undergoing antithrombotic therapy other than aspirin * Patients with atrial fibrillation * Patients with history of stroke within six months * Patients scheduled for major surgical procedures that will require aspirin discontinuation * Patients with contraindication of aspirin * Patients expected to have a prognosis of 1 year or less due to comorbidities * Women of child-bearing potential or women who have a positive pregnancy test at enrolment or randomization * Patients who are judged by attending physicians to be inappropriate to participate in this study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Kyoto University Hospital Kyoto Japan Recruiting

More Takeshi Morimoto trials in Japan

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05347069 on ClinicalTrials.gov ↗ ← All trials in Japan